Interconversion phenomena between two kinetic forms of class a pyruvate kinase from Ehrlich ascites tumor cells

Area of Science:

• Biochemistry
• Enzymology
• Cancer Cell Metabolism

Background:

• Pyruvate kinase (PK) is a key glycolytic enzyme regulating the final step of glycolysis.
• Class A pyruvate kinase from Ehrlich ascites tumor cells exists in interconvertible kinetic forms.
• Understanding PK regulation is crucial for comprehending cancer cell metabolism.

Purpose of the Study:

• To investigate the regulatory properties of two interconvertible kinetic forms of class A pyruvate kinase.
• To elucidate the roles of substrates and effectors in modulating enzyme kinetics and aggregation state.
• To propose a molecular model for pyruvate kinase A based on kinetic and aggregation data.

Main Methods:

• Studied partially purified class A pyruvate kinase from Ehrlich ascites tumor cells.
• Analyzed enzyme kinetics using varying substrate (P-pyruvate) and effector concentrations.
• Investigated enzyme aggregation state (dimer-tetramer equilibrium) using molecular weight determination.

Main Results:

• Identified hyperbolic and sigmoidal kinetic forms with distinct affinities for P-pyruvate and inhibitory amino acids.
• Demonstrated that substrates (P-pyruvate, ADP, Fru-P2) and effectors (ATP, alanine, phenylalanine) shift the equilibrium between kinetic forms.
• Showed that effectors modulate enzyme aggregation state, influencing the dimer-tetramer equilibrium.

Conclusions:

• Class A pyruvate kinase exhibits complex allosteric regulation through interconversion of kinetic and aggregation states.
• Metabolite effectors play a critical role in fine-tuning pyruvate kinase activity in cancer cells.
• A molecular model integrating kinetic and aggregation properties provides insights into pyruvate kinase A function.